H Ghali1, O Ben Rejeb2, N Bouafia3, A Ammar4, M Njah5, S Ernez6, A Mahdhaoui7, G Jeridi8. 1. Infection Prevention and Control Department, University Hospital Farhat Hached, Faculty of Medecine of Sousse, University of Sousse, Tunisia. Electronic address: yasminebenrejeb@hotmail.com. 2. Department of Cardiology, University Hospital Farhat Hached, Faculty of Medecine of Sousse, University of Sousse, Tunisia; Research Laboratory LR14ES05, Interactions of the Cardiopulmonary System, Faculty of Medicine of Sousse, University of Sousse, Tunisia. Electronic address: oussama_med1@yahoo.fr. 3. Infection Prevention and Control Department, University Hospital Farhat Hached, Faculty of Medecine of Sousse, University of Sousse, Tunisia; Infection Control Consultant, King Faycal Medical Complex, Taif, Saudi Arabia. Electronic address: nabiha.bouafia78@gmail.com. 4. Infection Prevention and Control Department, University Hospital Farhat Hached, Faculty of Medecine of Sousse, University of Sousse, Tunisia. Electronic address: asmamedcom@gmail.com. 5. Infection Prevention and Control Department, University Hospital Farhat Hached, Faculty of Medecine of Sousse, University of Sousse, Tunisia. Electronic address: njah.mansour@yahoo.fr. 6. Department of Cardiology, University Hospital Farhat Hached, Faculty of Medecine of Sousse, University of Sousse, Tunisia. Electronic address: samiaernezhajri@live.fr. 7. Department of Cardiology, University Hospital Farhat Hached, Faculty of Medecine of Sousse, University of Sousse, Tunisia; Research Laboratory LR14ES05, Interactions of the Cardiopulmonary System, Faculty of Medicine of Sousse, University of Sousse, Tunisia. Electronic address: abdallahmahdhaoui@topnet.tn. 8. Department of Cardiology, University Hospital Farhat Hached, Faculty of Medecine of Sousse, University of Sousse, Tunisia; Research Laboratory LR14ES05, Interactions of the Cardiopulmonary System, Faculty of Medicine of Sousse, University of Sousse, Tunisia. Electronic address: gouiderjeridi@yahoo.fr.
Abstract
AIM: The purpose of our study was to determine the incidence and risk factors of Peripheral Venous Catheter-Related Adverse Events (PVCAEs) in a cardiology department of a university hospital. PATIENTS AND METHODS: We carried out a prospective observational study from Mars 2017 to May 2017 in the cardiology department of the University Hospital of Farhat Hached in Sousse, Tunisia. During this period, we actively followed-up all inserted PVCs (every 12hours) from insertion up to 48hours after removal. Regression analyses were applied and significance limits were set at P<0.05. RESULTS: Data were analysed for 210 PVCs (794 PVC-days) in 148 patients. The incidence of PVCAEs was 33.33% with density of incidence of 8.81/1000 PVC-days. PVCAEs were mainly pain (50%) and mechanical events (31.42%). Infections accounted for 11.42%. The most frequent mechanical PVCAEs, was haematoma (15.71%). Multivariate analysis revealed as independent factors for the occurrence of PVCAEs: the hydro electrolytic nature of the injected product (OR=13.42, P<10-3), the medicinal nature of the injected product (OR=5.08, P=0.003), bad cutaneous state (OR=8.08, P=0.003), admission during nightshift (OR=3.76; P=0.014) and advanced age (OR=1.04, P=0.042). CONCLUSION: Multicenter studies would be very useful to better analyze risk factors associated with PVCAEs.
AIM: The purpose of our study was to determine the incidence and risk factors of Peripheral Venous Catheter-Related Adverse Events (PVCAEs) in a cardiology department of a university hospital. PATIENTS AND METHODS: We carried out a prospective observational study from Mars 2017 to May 2017 in the cardiology department of the University Hospital of Farhat Hached in Sousse, Tunisia. During this period, we actively followed-up all inserted PVCs (every 12hours) from insertion up to 48hours after removal. Regression analyses were applied and significance limits were set at P<0.05. RESULTS: Data were analysed for 210 PVCs (794 PVC-days) in 148 patients. The incidence of PVCAEs was 33.33% with density of incidence of 8.81/1000 PVC-days. PVCAEs were mainly pain (50%) and mechanical events (31.42%). Infections accounted for 11.42%. The most frequent mechanical PVCAEs, was haematoma (15.71%). Multivariate analysis revealed as independent factors for the occurrence of PVCAEs: the hydro electrolytic nature of the injected product (OR=13.42, P<10-3), the medicinal nature of the injected product (OR=5.08, P=0.003), bad cutaneous state (OR=8.08, P=0.003), admission during nightshift (OR=3.76; P=0.014) and advanced age (OR=1.04, P=0.042). CONCLUSION: Multicenter studies would be very useful to better analyze risk factors associated with PVCAEs.
Authors: Pedro Parreira; Beatriz Serambeque; Paulo S Costa; Lisete S Mónico; Vânia Oliveira; Liliana B Sousa; Fernando Gama; Rafael A Bernardes; David Adriano; Inês A Marques; Luciene M Braga; João Graveto; Nádia Osório; Anabela Salgueiro-Oliveira Journal: Int J Environ Res Public Health Date: 2019-09-08 Impact factor: 3.390